Roivant Sciences Ltd.
シンボルマーク: ROIV
NASDAQ
11.25
USD今日の市場価格
2.0826
PER（株価収益率
0.0316
PEGレシオ
9.07B
MRK キャップ
- 0.00%
DIV利回り
Roivant Sciences Ltd. (ROIV) 財務諸表
貸借対照表
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1692.1 | 2074 | 2055 | |||||
balance-sheet.row.short-term-investments | 0 | 15.3 | 13.6 | 0 | |||||
balance-sheet.row.net-receivables | 0 | 32.7 | 6.7 | 13.8 | |||||
balance-sheet.row.inventory | 0 | 2.8 | -16.5 | 63.9 | |||||
balance-sheet.row.other-current-assets | 0 | 121.8 | 82.2 | 54.3 | |||||
balance-sheet.row.total-current-assets | 0 | 1798.6 | 2146.5 | 2187 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 92.3 | 86.9 | 77 | |||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.intangible-assets | 0 | 144.9 | 0 | 0 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 144.9 | 0 | 0 | |||||
balance-sheet.row.long-term-investments | 0 | 304.3 | 325.8 | 289.5 | |||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.other-non-current-assets | 0 | 49.5 | 25.8 | 36.1 | |||||
balance-sheet.row.total-non-current-assets | 0 | 591 | 438.6 | 402.7 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 2389.6 | 2585.1 | 2589.7 | |||||
balance-sheet.row.account-payables | 0 | 37.8 | 34.6 | 20.6 | |||||
balance-sheet.row.short-term-debt | 0 | 52.4 | 11.4 | 12.3 | |||||
balance-sheet.row.tax-payables | 0 | 0.5 | 0.7 | 0.2 | |||||
balance-sheet.row.long-term-debt-total | 0 | 429 | 272.5 | 232.7 | |||||
Deferred Revenue Non Current | 0 | 0 | 13.7 | 0 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 15.1 | 128.2 | 180.2 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 509.6 | 339.3 | 308.7 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 22.5 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 65.2 | 73.9 | 74.7 | |||||
balance-sheet.row.total-liab | 0 | 782 | 546.2 | 527.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.retained-earnings | 0 | -3772.8 | -2763.7 | -1918.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -2.6 | -0.9 | 1.4 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 5383 | 4803.6 | 3714.8 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 1607.6 | 2038.9 | 1797.8 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2389.6 | 2585.1 | 2589.7 | |||||
balance-sheet.row.minority-interest | 0 | 449.8 | 404.5 | 264.2 | |||||
balance-sheet.row.total-equity | 0 | 2057.4 | 2443.4 | 2062 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 304.3 | 325.8 | 289.5 | |||||
balance-sheet.row.total-debt | 0 | 481.4 | 283.9 | 245 | |||||
balance-sheet.row.net-debt | 0 | -1195.4 | -1776.5 | -1810.1 |
キャッシュフロー計算書
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -1115.5 | -924.1 | -900.2 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 18.9 | 5.9 | 0 | |||||
cash-flows.row.deferred-income-tax | 0 | -4.4 | -5.9 | 0 | |||||
cash-flows.row.stock-based-compensation | 0 | 217.8 | 565 | 85 | |||||
cash-flows.row.change-in-working-capital | 0 | 6.3 | 15.7 | 71.9 | |||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||
cash-flows.row.account-payables | 0 | 4.4 | 15.4 | 3.8 | |||||
cash-flows.row.other-working-capital | 0 | 2 | 0.3 | 68.2 | |||||
cash-flows.row.other-non-cash-items | 0 | 33.4 | -334.3 | 191.2 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -12.7 | -17.4 | -5.8 | |||||
cash-flows.row.acquisitions-net | 0 | 107.9 | 0 | 0 | |||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -28.3 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 320.2 | 0 | |||||
cash-flows.row.other-investing-activites | 0 | -139.4 | 0.6 | 2.4 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -44.3 | 303.3 | -31.7 | |||||
cash-flows.row.debt-repayment | 0 | -30.1 | -21.6 | 0 | |||||
cash-flows.row.common-stock-issued | 0 | 379.7 | 313.4 | 455.8 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0.3 | 0 | -0.1 | |||||
cash-flows.row.dividends-paid | 0 | -162.7 | 0 | 0 | |||||
cash-flows.row.other-financing-activites | 0 | 312.3 | 15 | 0.6 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 499.5 | 306.8 | 456.3 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 6.3 | 0 | 0 | |||||
cash-flows.row.net-change-in-cash | 0 | -381.9 | -67.6 | -127.6 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 1692.1 | 2074 | 2141.7 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 2074 | 2141.7 | 2269.3 | |||||
cash-flows.row.operating-cash-flow | 0 | -843.4 | -677.7 | -552.1 | |||||
cash-flows.row.capital-expenditure | 0 | -12.7 | -17.4 | -5.8 | |||||
cash-flows.row.free-cash-flow | 0 | -856.1 | -695.2 | -557.9 |
損益計算書の行
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 61.3 | 55.3 | 23.8 | |||||
income-statement-row.row.cost-of-revenue | 0 | 13.1 | 9 | 2.1 | |||||
income-statement-row.row.gross-profit | 0 | 48.2 | 46.3 | 21.7 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | -62.2 | -0.1 | -33.4 | |||||
income-statement-row.row.operating-expenses | 0 | 1125.7 | 1258.1 | 496.5 | |||||
income-statement-row.row.cost-and-expenses | 0 | 1138.8 | 1267 | 498.6 | |||||
income-statement-row.row.interest-income | 0 | 32.2 | 0.4 | 1.4 | |||||
income-statement-row.row.interest-expense | 0 | 28 | 7 | 2.8 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -147.3 | 288 | 172.4 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | -62.2 | -0.1 | -33.4 | |||||
income-statement-row.row.total-operating-expenses | 0 | -147.3 | 288 | 172.4 | |||||
income-statement-row.row.interest-expense | 0 | 28 | 7 | 2.8 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | -30 | -288.1 | 560.4 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | -1077.6 | -1211.7 | -1070.9 | |||||
income-statement-row.row.income-before-tax | 0 | -1224.8 | -923.7 | -898.5 | |||||
income-statement-row.row.income-tax-expense | 0 | 5.2 | 0.4 | 1.7 | |||||
income-statement-row.row.net-income | 0 | -1230 | -924.1 | -900.2 |
よくある質問
Roivant Sciences Ltd.ROIV 総資産とは何ですか？
Roivant Sciences Ltd. (ROIV) 総資産は 2389604000.000.
企業の年間売上高とは？
年間収益は N/Aである.
企業の利益率は？
利益率は 0.876 である.
企業のフリーキャッシュフローとは？
フリーキャッシュフローは -1.047.
企業の純利益率は？
純利益率は 35.091 である.
企業の総収入は？
総収入は 39.165 である.
Roivant Sciences Ltd. (ROIV) 純利益（純利益）とは何ですか？
純利益（純利益）は -1230024000.000.
負債総額は？
負債合計は 481404000.000 である.
営業費用はいくらですか？
営業費用は 1125721000.000 である.
会社の現金はいくらですか？
企業の現金は 0.000 である.